Ovarian carcinoma. Residual therapy with pegylated liposomal doxorubicin?
Musch, A.
Medizinische Monatsschrift für Pharmazeuten 28(12): 453-455
2005
ISSN/ISBN: 0342-9601 PMID: 16389880 Document Number: 590411
Document emailed within 1 workday
Related Documents
Gorumlu, G.; Kucukzeybek, Y.; Kemal-Gul, M.; Karaca, B.; Cosan-Terek, M.; Karabulut, B.; Sanli, U.A.; Akman, L.; Ozsaran, A.; Dikmen, Y.; Uslu, R. 2008: Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(3): 349-352Mrochen-Domin, I.; Nowara, E.; Kaleta, B. 2008: "Hand-foot" syndrome--after liposomal pegylated doxorubicin in patients with the ovarian cancer recurrence (own experiences) Ginekologia Polska 79(5): 332-337
Korver, G.E.; Ronald, H.; Petersen, M.J. 2006: An intertrigo-like eruption from pegylated liposomal doxorubicin Journal of Drugs in Dermatology: Jdd 5(9): 901-902
Capitain, O.; Lortholary, A. 2003: Absence of cutaneous complications following extravasation of pegylated liposomal doxorubicin Presse Medicale 32(23): 1077
Kanis, M.; Kesterson, J.P.; Lele, S. 2009: The use of cod liver oil by patients receiving pegylated liposomal doxorubicin is associated with a lack of severe palmar-plantar erythrodysesthesia European Journal of Gynaecological Oncology 30(4): 387-388
Gonçalves, A.; Braud, A.C.; Viret, F.; Genre, D.; Gravis, G.; Tarpin, C.; Giovannini, M.; Maraninchi, D.; Viens, P. 2003: Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors Anticancer Research 23(4): 3543-3548
Isaka, M.; Imamura, M.; Sakuma, I.; Shiiya, N.; Ishizuka, T.; Ogata, Y.; Yasuda, K. 2007: Experimental study of pegylated liposomal hemoglobin on norepinephrine release and reperfusion arrhythmias in isolated guinea pig hearts Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 13(6): 391-395
Stevens, P.J.; Lee, R.J. 2003: Formulation kit for liposomal doxorubicin composed of lyophilized liposomes Anticancer Research 23(1a): 439-442
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Vogl, S.E.; Pagano, M.; Kaplan, B.H.; Einhorn, N.; Arseneau, J.; Moukhtar, M.; Greenwald, E. 1980: Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy Obstetrics and Gynecology 56(5): 635-640
Edmonson, J.H.; Fleming, T.R.; Decker, D.G.; Malkasian, G.D.; Jorgensen, E.O.; Jefferies, J.A.; Webb, M.J.; Kvols, L.K. 1979: Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease Cancer Treatment Reports 63(2): 241-247
Sorbe, B.; Hallén, C. 1991: Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients European Journal of Gynaecological Oncology 12(1): 31-37
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Plasswilm, L. 2000: Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(12): 583-584
Shimura, H.; Hara, Y.; Ida, T. 1993: A case report of markedly effective recombinant interferon therapy in residual tumor of renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 39(3): 261-263
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Sevelda, P. 1996: Surgical therapy of ovarian carcinoma Wiener Medizinische Wochenschrift 146(1-2): 18-22
Kudela, M. 1977: Therapy of ovarian carcinoma with olivomycin Ceskoslovenska Gynekologie 42(10): 746-747
Geary, M.; Foley, M.; Lenehan, P.; Murphy, J.; Fennelly, J. 1995: Recurrent ovarian carcinoma: diagnosis and second-line therapy Irish Medical Journal 88(2): 68-70
Krafft, W.; Steuckart, R.; Preibsch, W.; Behling, H.; Brückmann, D.; Schirmer, A.; Kademann, J. 1983: Problems in the therapy of ovarian carcinoma with gestagen-acting hormones Zentralblatt für Gynakologie 105(9): 560-565